Feasibility Study of i-ACT in Aged Persons (i-ACT-aged)

July 27, 2020 updated by: PXL University College

Intelligent Activity-based Client-centred Training (i-ACT) in Aged Persons

A mix-method cross-sectional feasibility study performed in five aged care institutes in Flanders, Belgium. A convenience sample of 48 aged persons was recruited and 12 supervisors (i.e. occupational therapy students and therapists).

Aged persons received a 20-30 minutes test with a technology-based system, i.e. intelligent Activity-based Client-centred Training system (i-ACT). The i-ACT consists of the Microsoft Kinect and adapted software in which movements can be recorded and training parameters can be set by supervisors.

During and after the test, the thinking aloud method was used. After the test, the Intrinsic Motivation Inventory, the System Usability Scale, and the Credibility/Expectancy Questionnaire were administered in the aged persons.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Hasselt, Limburg, Belgium, 3500
        • Plankeweeke
      • Riemst, Limburg, Belgium, 3770
        • Begralim
      • Tongeren, Limburg, Belgium, 3717
        • Begralim
      • Zonhoven, Limburg, Belgium, 3520
        • DVC H. Catharina
      • Zonhoven, Limburg, Belgium, 3520
        • WZC H. Catharina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • a client of the participating centres
  • cognitively able to understand and respond to questions
  • follow up instructions
  • understand and speak the Dutch language

Exclusion Criteria:

  • severe spasticity that unables participants to perform exercises
  • severe visual impairment (e.g. blindness, cataract, etc.)
  • severe communication disorder that unables participants to understand and follow up instructions (e.g. aphasia, agnosia, etc.)
  • persons who use electric wheelchairs who are not able to make a transfer towards a chair.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Aged persons
A feasibility test of 20-30 minutes in aged persons with an adapted Kinect-based system, i.e. i-ACT.
Performing exercises with an adapted motion detection device (i.ACT) for 20-30 minutes.
Other Names:
  • Kinect

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intrinsic motivation
Time Frame: 30 minutes
Using the Intrinsic Motivation Inventory to record motivational aspects
30 minutes
Usability of i-ACT
Time Frame: 10 minutes
Using the System Usability Scale to explore the usability of i-ACT in aged persons. The System Usability Scale consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. The items scores are converted into a score from 0 (negative) to 100 (positive). A score of 72.5 or higher is considered good and above 85.0 is excellent.
10 minutes
Credibility/expectancy
Time Frame: 10 minutes
Using the Credibility/Expectancy Questionnaire to research the credibility and expectancy of aged persons when using the i-ACT for physical activity. It is one test that consists of 2 subscales, i.e. credibility and expectancy, and scores range from 1 (totally not) to 9 (totally yes) and percentages. The percentages are converted to scores on a scale of 1 to 9/ The maximum score on each subscale is 27. A score of 13.5 is considered neutral, everything above 13.5 is positive while everything under 13.5 is considered negative.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

May 12, 2019

Study Completion (Actual)

May 12, 2019

Study Registration Dates

First Submitted

July 23, 2020

First Submitted That Met QC Criteria

July 27, 2020

First Posted (Actual)

July 28, 2020

Study Record Updates

Last Update Posted (Actual)

July 28, 2020

Last Update Submitted That Met QC Criteria

July 27, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • i-ACT elderly

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feasibility of a Technology-based System in Aged Person

Clinical Trials on i-ACT

Subscribe